Format

Send to

Choose Destination
N Engl J Med. 2017 May 4;376(18):1706-1708. doi: 10.1056/NEJMp1701047.

The Failure of Solanezumab - How the FDA Saved Taxpayers Billions.

Author information

1
From the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston.
PMID:
28467878
DOI:
10.1056/NEJMp1701047
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center